Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
China · Delayed Price · Currency is CNY 8.55
-0.18 (-2.06%)
Nov 13, 2026, 3:04 PM CST
SHE:002693 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 48.75 | 59.05 | 45.11 | 3.39 | 12.2 | 21.62 |
Trading Asset Securities | 4.92 | 0.05 | 0 | 28.52 | 133.81 | 55.4 |
Cash & Short-Term Investments | 53.67 | 59.1 | 45.11 | 31.9 | 146.01 | 77.02 |
Cash Growth | -2.28% | 31.01% | 41.39% | -78.15% | 89.57% | -23.02% |
Accounts Receivable | 40.4 | 66.83 | 15.17 | 16.36 | 28.13 | 20.77 |
Other Receivables | 11.46 | 11.65 | 11.39 | 11.74 | 11.58 | 11.85 |
Receivables | 51.86 | 78.48 | 26.56 | 28.1 | 39.71 | 32.62 |
Inventory | 105.65 | 66.09 | 80.54 | 74.31 | 65.41 | 55.24 |
Other Current Assets | 6.32 | 1.05 | 3.76 | 0.93 | 1.26 | 0.57 |
Total Current Assets | 217.5 | 204.71 | 155.97 | 135.24 | 252.39 | 165.45 |
Property, Plant & Equipment | 387.74 | 399.69 | 420.62 | 457.6 | 471.77 | 504.73 |
Long-Term Investments | - | - | - | 10 | - | - |
Other Intangible Assets | 115.69 | 104.88 | 57.92 | 52.81 | 72.09 | 78.82 |
Long-Term Deferred Tax Assets | 1.22 | 1.37 | 1 | 1.52 | 0.97 | 1.03 |
Long-Term Deferred Charges | 85.51 | 90.34 | 124.25 | 124.22 | 96.3 | 80.14 |
Other Long-Term Assets | 21 | 24.77 | 24.1 | 21.87 | 17.5 | 24.38 |
Total Assets | 828.66 | 825.78 | 783.87 | 803.25 | 911.02 | 854.56 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 35.3 | 23.84 | 21.09 | 17.14 | 15.5 | 17.16 |
Accrued Expenses | 7.56 | 30.44 | 16.38 | 24.52 | 36.35 | 40.61 |
Short-Term Debt | - | 67.02 | 63.45 | 41 | 18.06 | 10.45 |
Current Portion of Long-Term Debt | 171.19 | 124.72 | 28.26 | 10.05 | 205.3 | 0.25 |
Current Income Taxes Payable | 6.75 | - | - | - | - | - |
Current Unearned Revenue | 54.74 | 51.73 | 38.78 | 31.88 | 23.53 | 12.35 |
Other Current Liabilities | 78.61 | 9.09 | 9.02 | 15.36 | 20.62 | 27.59 |
Total Current Liabilities | 354.15 | 306.83 | 176.99 | 139.94 | 319.36 | 108.41 |
Long-Term Debt | 25.5 | 89 | 184.5 | 135 | - | 167 |
Long-Term Unearned Revenue | 8.8 | 7.59 | 8.56 | 8.03 | 7.64 | 8.87 |
Long-Term Deferred Tax Liabilities | 1.62 | 1.82 | 2.21 | 2.63 | 3.08 | 3.53 |
Total Liabilities | 390.07 | 405.25 | 372.26 | 285.6 | 330.08 | 287.8 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 414.69 | 414.69 | 414.69 | 416.73 | 414.74 | 412 |
Additional Paid-In Capital | 369.91 | 369.91 | 369.91 | 371.65 | 368.98 | 354.38 |
Retained Earnings | -349.35 | -371.8 | -390.84 | -312.53 | -261.79 | -270.8 |
Treasury Stock | - | - | - | -4.01 | -8.02 | -13.37 |
Comprehensive Income & Other | -0.35 | -0.35 | -0.35 | -0.35 | -0.36 | -0.36 |
Total Common Equity | 434.9 | 412.46 | 393.41 | 471.49 | 513.55 | 481.85 |
Minority Interest | 3.69 | 8.07 | 18.2 | 46.16 | 67.39 | 84.9 |
Shareholders' Equity | 438.59 | 420.53 | 411.61 | 517.65 | 580.94 | 566.75 |
Total Liabilities & Equity | 828.66 | 825.78 | 783.87 | 803.25 | 911.02 | 854.56 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 196.69 | 280.73 | 276.21 | 186.05 | 223.36 | 177.7 |
Net Cash (Debt) | -143.02 | -221.64 | -231.1 | -154.15 | -77.35 | -100.67 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.37 | -0.58 | -0.56 | -0.36 | -0.17 | -0.25 |
Filing Date Shares Outstanding | 416.37 | 414.69 | 414.69 | 416.73 | 414.74 | 412 |
Total Common Shares Outstanding | 416.37 | 414.69 | 414.69 | 416.73 | 414.74 | 412 |
Working Capital | -136.65 | -102.12 | -21.02 | -4.71 | -66.97 | 57.04 |
Book Value Per Share | 1.04 | 0.99 | 0.95 | 1.13 | 1.24 | 1.17 |
Tangible Book Value | 319.21 | 307.57 | 335.49 | 418.68 | 441.46 | 403.03 |
Tangible Book Value Per Share | 0.77 | 0.74 | 0.81 | 1.00 | 1.06 | 0.98 |
Buildings | - | 388.73 | 388.73 | 388.5 | 388.67 | 388.28 |
Machinery | - | 455.58 | 441.57 | 435.36 | 418.58 | 406.11 |
Construction In Progress | - | 23.86 | 16.99 | 18 | 4.14 | 3.02 |